Abstract
Cerebrovascular disease is the leading cause of death and disability in Japan and most Western countries. Gene transfer techniques may be applicable to the treatment of serious types of stroke, since several experimental studies have revealed the usefulness of gene therapy in the prevention of vasospasm after subarachnoid hemorrhage, reduction of infarct size and improvement of neuronal functions. Midkine is reported to have anti-apoptotic effects, and the gene transfer of midkine to the ischemic brain may provide neuroprotective effects. Furthermore, chemotactic effects of midkine could be utilized for the neurogenesis and functional recovery. We describe the novel possibility of the stroke treatment using midkine gene transfer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Verma IM, Somia N (1997) Gene therapy promises, problems and prospects. Nature 389:239–242
Isner JM (2002) Myocardial gene therapy. Nature 415:234–239
Heistad DD, Faraci FM (1996) Gene therapy for cerebral vascular disease. Stroke 27:1688–1693
Isner JM, Vale PR, Symes JF et al (2001) Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 89:389–400
Schneider MD, French BA (1993) The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation 88:1937–1942
Lin H, Parmacek MS, Morle G et al (1990) Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 82:2217–2221
Shen F, Su H, Fan Y et al (2006) Adeno-associated viral-vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. Stroke 37:2601–2606
Hacein-Bey-Abina S, Hauer J, Lim A et al (2010) Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 363:355–364
Okano S, Yonemitsu Y, Shirabe K et al (2011) Provision of continuous maturation signaling to Dendritic cells by RIG-I-stimulating cytosolic RNA synthesis of Sendai virus. J Immunol 186:1828–1839
Nabel EG, Plautz G, Nabel GJ (1990) Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249:1285–1288
Toyoda K, Ooboshi H, Chu Y et al (1998) Cationic molecules enhance adenovirus-mediated gene transfer to the carotid artery. Stroke 29:2181–2187
Rios CD, Ooboshi H, Piegors D et al (1995) Adenovirus-mediated gene transfer to normal and atherosclerotic arteries. A novel approach. Arterioscler Thromb Vasc Biol 15:2241–2245
Ooboshi H, Welsh MJ, Rios CD et al (1995) Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res 77:7–13
Christenson SD, Lake KD, Ooboshi H et al (1998) Adenovirus-mediated gene transfer to cerebral blood vessels and perivascular tissue in mice. Stroke 29:1411–1416
Muhonen MG, Ooboshi H, Welsh MJ et al (1997) Gene transfer to cerebral blood vessels after subarachnoid hemorrhage. Stroke 28:822–828
Toyoda K, Faraci FM, Watanabe Y et al (2000) Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res 87:818–824
Watanabe Y, Chu Y, Andresen JJ et al (2003) Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 34:434–440
Hossmann KA (1994) Viability thresholds and the penumbra of focal ischemia. Ann Neurol 36:557–565
Xie Y, Mies G, Hossmann KA (1989) Ischemic threshold of brain protein synthesis after unilateral carotid artery occlusion in gerbils. Stroke 20:620–626
Ooboshi H, Ibayashi S, Takada J et al (2001) Adenovirus-mediated gene transfer to ischemic brain. Ischemic flow threshold for transgene expression. Stroke 32:1043–1047
Takada J, Ooboshi H, Yao H et al (2003) Adenovirus-mediated gene transfer to ischemic brain is augmented in aged rats. Exp Gerontol 38:423–429
Yenari MA, Fink SL, Sun GH et al (1998) Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol 44:584–591
Ooboshi H, Chu Y, Rios CD et al (1997) Altered vascular function following adenovirus-mediated overexpression of endothelial nitric oxide synthase. Am J Physiol 273:H265–H270
Ooboshi H, Toyoda K, Faraci FM et al (1998) Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol 18:1752–1758
Ooboshi H, Rios CD, Heistad DD (1997) Novel methods for adenovirus-mediated gene transfer to blood vessels in vivo. Mol Cell Biochem 172:37–46
Kumai Y, Ooboshi H, Kitazono T et al (2003) Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats. Exp Neurol 184:904–911
Kadomatsu K, Tomomura M, Muramatsu T (1988) cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 151:1312–1318
Kikuchi S, Muramatsu H, Muramatsu T et al (1993) Midkine, a novel neurotrophic factor, promotes survival of mesencephalic neurons in culture. Neurosci Lett 160:9–12
Yoshida Y, Goto M, Tsutsui J et al (1995) Midkine is present in the early stage of cerebral infarct. Brain Res Dev Brain Res 85:25–30
Owada K, Sanjo N, Kobayashi T et al (1999) Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem 73:2084–2092
Takada J, Ooboshi H, Ago T et al (2005) Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther 12:487–493
Sumida A, Horiba M, Ishiguro H et al (2010) Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res 86:113–121
Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819–834
Kumai Y, Ooboshi H, Takada J et al (2004) Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats. J Cereb Blood Flow Metab 24:1359–1368
Yilmaz G, Arumugam TV, Stokes KY et al (2006) Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113:2105–2112
Shichita T, Sugiyama Y, Ooboshi H et al (2009) Pivotal role of cerebral interleukin-17-producing γδT cells in the late phase of ischemic brain injury. Nat Med 15:946–950
Liesz A, Suri-Payer E, Veltkamp C et al (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15:192–199
Ooboshi H, Ibayashi S, Shichita T et al (2005) Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111:913–919
del Zoppo GJ (2006) Stroke and neurovascular protection. N Engl J Med 354:553–555
Su EJ, Fredriksson L, Geyer M et al (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731–737
Kumai Y, Ooboshi H, Ibayashi S et al (2007) Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability. J Cereb Blood Flow Metab 27:1152–1160
Temple S (2001) The development of neural stem cells. Nature 414:112–117
Nakatomi H, Kuriu T, Okabe S et al (2002) Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110:429–441
Arvidsson A, Collin T, Kirik D et al (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8:963–970
Sugiura S, Kitagawa K, Tanaka S et al (2005) Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke 36:859–864
Matsuzawa M, Muramatsu T, Yamamori T (1999) Novel neuronal effects of midkine on embryonic cerebellar neurons examined using a defined culture system. Cell Mol Neurobiol 19:209–221
Horiba M, Kadomatsu K, Nakamura E et al (2000) Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105:489–495
Choudhuri R, Zhang HT, Donnini S et al (1997) An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 57:1814–1819
Ishikawa E, Ooboshi H, Kumai Y et al (2009) Midkine gene transfer protects against focal brain ischemia and augments neurogenesis. J Neurol Sci 285:78–84
Biebl M, Cooper CM, Winkler J et al (2000) Analysis of neurogenesis and programmed cell death reveals a selfrenewing capacity in the adult rat brain. Neurosci Lett 291:17–20
Acknowledgements
We would like to thank the University of Iowa Gene Transfer Vector Core, especially Beverly L. Davidson.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Funding: This work was supported by the Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (S0801084, 23591262), Tokyo, Japan.
Conflict of interest: None.
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Ooboshi, H., Ishikawa, E., Takada, J., Shichita, T., Kumai, Y. (2012). Midkine Gene Transfer in Brain Infarction. In: Ergüven, M., Muramatsu, T., Bilir, A. (eds) Midkine: From Embryogenesis to Pathogenesis and Therapy. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4234-5_13
Download citation
DOI: https://doi.org/10.1007/978-94-007-4234-5_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4233-8
Online ISBN: 978-94-007-4234-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)